Published in Chest on November 01, 1998
The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med (2006) 2.21
The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia (2002) 1.96
Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg (2004) 1.62
Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. World J Surg (2013) 1.13
Prevention of venous thromboembolism in spinal surgery. Eur Spine J (2003) 1.12
Prophylaxis in elective colorectal surgery: the cost of ignoring the evidence. Can J Surg (2003) 1.10
Thromboprophylaxis after replacement arthroplasty. BMJ (2001) 1.10
Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients. Thromb Res (2009) 1.07
Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Crit Care (2001) 1.05
Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg (2013) 1.02
Arterial and venous thrombosis in cancer patients. Cardiol Res Pract (2011) 0.97
Foot pump prophylaxis for deep venous thrombosis-rate of effective usage following knee and hip arthroplasty. Int Orthop (2003) 0.90
Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study. Thromb J (2004) 0.90
Quality and safety in surgical care. Ann Surg (2006) 0.87
Clinical and critical care concerns in severely ill obese patient. Indian J Endocrinol Metab (2012) 0.86
Comparison of laparoscopy and laparotomy for management of endometrial carcinoma: a prospective randomized study with 11-year experience. J Cancer Res Clin Oncol (2013) 0.86
Alterations in homeostasis after open surgery. A prospective randomized study. G Chir (2013) 0.84
Fibrinolytic and coagulation pathways after laparoscopic and open surgery: a prospective randomized trial. Surg Endosc (2009) 0.83
Polysaccharide-based micelles for drug delivery. Pharmaceutics (2013) 0.81
Virchow's Legacy: deep vein thrombosis and pulmonary embolism. World J Surg (2005) 0.80
Prevention of venous thromboembolism in Wales: results of a survey among general surgeons. Postgrad Med J (2002) 0.79
The cancer stem cell: evidence for its origin as an injured autoreactive T cell. Mol Cancer (2006) 0.77
Low-molecular-weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients. Exp Ther Med (2015) 0.75
Venous thromboembolism deserves your attention. Crit Care (2001) 0.75
A cohort study to analyze the risk of venous thromboembolism mortality in patients admitted to the general medicine department, tan tock seng hospital, singapore. Int J Angiol (2011) 0.75
Deep Vein Thrombosis in Elderly Patients following Surgery for Fracture of the Proximal Femur. Malays Orthop J (2014) 0.75
Systemic inflammatory response syndrome and platelet count ≥250×10(9) are associated with venous thromboembolic disease. Int J Gen Med (2015) 0.75
Risks vs benefits in total joint surgery. Chest (1999) 0.75
Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence. Thrombosis (2013) 0.75
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Prevention of venous thromboembolism. Chest (2001) 5.59
Homotransplantation of the Canine Liver as an Orthotopic Vascularized Graft: Histologic and Functional Correlations During Residence in the New Host. Am J Pathol (1962) 3.14
Prevention of venous thromboembolism. Chest (1995) 2.69
Biogenesis of zearalenone (F-2) by Fusarium roseum 'Graminearum'. Can J Microbiol (1974) 2.33
Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart (2009) 2.28
Colorectal foreign bodies. Colorectal Dis (2005) 2.28
The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96
Publication rate of abstracts presented at the annual meeting of the Orthopaedic Research Society. J Orthop Res (1998) 1.91
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Prevention of venous thromboembolism. Chest (1992) 1.81
American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70
Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost (2012) 1.66
Physician practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg (1992) 1.63
Extended indications for placement of an inferior vena cava filter. J Vasc Surg (1989) 1.62
Influence of health status and the timing of surgery on mortality in hip fracture patients. Am J Orthop (Belle Mead NJ) (1997) 1.62
Overlapping PCR for bidirectional PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes. Genome Res (1997) 1.60
Multicenter, randomized, prospective trial of early tracheostomy. J Trauma (1997) 1.59
An assessment of orthopaedic surgeons' knowledge of medical ethics. J Bone Joint Surg Am (1998) 1.59
Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med (1994) 1.54
Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. J Bone Joint Surg Am (1988) 1.53
Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes. Heart (2010) 1.53
The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study. Thromb Haemost (1998) 1.49
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med (2004) 1.48
Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart (2007) 1.47
Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood (2001) 1.46
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost (1995) 1.44
The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE. Heart (2010) 1.32
Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg Br (2003) 1.31
Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res (1996) 1.30
Physician practices in the prevention of venous thromboembolism. Ann Intern Med (1991) 1.28
Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med (1987) 1.20
Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.17
Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone (2007) 1.16
The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. Diagn Microbiol Infect Dis (1994) 1.15
Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med (2000) 1.15
Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res (1998) 1.14
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res (2003) 1.14
The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc (2000) 1.13
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost (2010) 1.12
The accuracy of assessing total hip arthroplasty outcomes: a prospective correlation study of walking ability and 2 validated measurement devices. J Arthroplasty (2000) 1.12
Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma (1995) 1.11
Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg (1997) 1.11
Polyethylene and metal debris generated by non-articulating surfaces of modular acetabular components. J Bone Joint Surg Br (1994) 1.09
Energy requirements for the action of staphylococcin 1580 in Staphyloccus aureus. Biochim Biophys Acta (1978) 1.08
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost (2005) 1.06
Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. J Bone Joint Surg Am (2005) 1.06
Limitations of pulsed-field gel electrophoresis for the routine surveillance of Campylobacter infections. J Infect Dis (2001) 1.04
Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med (1999) 1.03
Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol (2001) 1.03
The use of 18F-fluoride and 18F-FDG PET scans to assess fracture healing in a rat femur model. Eur J Nucl Med Mol Imaging (2007) 1.03
Axillary artery compression and thrombosis in throwing athletes. J Vasc Surg (1990) 1.02
The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med (1992) 1.02
Requirement of the light-harvesting pigment.protein complex for magnesium ion regulation of excitation energy distribution in chloroplasts. Biochim Biophys Acta (1978) 1.01
Noninvasive detection of carotid stenosis following endarterectomy. Arch Surg (1981) 1.01
Prediction of the development of sigmoid ischemia on the day of aortic operations. Indirect measurements of intramural pH in the colon. Arch Surg (1986) 1.01
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Single plane and biplane external fixators for knee arthrodesis. Clin Orthop Relat Res (1995) 1.00
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med (1992) 1.00
Regional gene therapy to enhance bone repair. Gene Ther (2004) 0.99
Complications of femoral and acetabular modularity. Clin Orthop Relat Res (1995) 0.98
Occlusive impedance phlebography: a diagnostic procedure for venous thrombosis and pulmonary embolism. Prog Cardiovasc Dis (1975) 0.97
Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc (1999) 0.97
Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J Neurosci Res (1998) 0.95
Compression of the inferior vena cava by right renal cysts: an unusual cause of IVC and/or iliofemoral thrombosis with pulmonary embolism in autosomal dominant polycystic kidney disease. Clin Nephrol (1998) 0.94
Conditional killing effect of staphylococcin 1580 and repair of sublethal injury in Staphylococcus aureus. Antimicrob Agents Chemother (1977) 0.94
Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med (2000) 0.94
Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism. Thromb Res (2008) 0.93
Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol (1999) 0.93
Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism. Thromb Res (2010) 0.93
The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology (2000) 0.92
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. J Thromb Haemost (2003) 0.92
The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord (2001) 0.92
Motor neuron degeneration is attenuated in bax-deficient neurons in vitro. J Neurosci Res (1999) 0.91
Zinc-induced neuronal death in cortical neurons. Cell Mol Biol (Noisy-le-grand) (2000) 0.91
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med (1990) 0.91
Ultra-high-molecular weight polyethylene wear: an in vitro comparison of acetabular metal types and polished surfaces. J Arthroplasty (1999) 0.91
Intraoperative complications during total hip arthroplasty. Orthopedics (1995) 0.90
Recommendations for incorporating palliative care education into the acute care hospital setting. Acad Med (1999) 0.90
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol (1992) 0.90
A prospective study of the incidence of deep venous thrombosis in hospitalized children. J Vasc Surg (1996) 0.90
Applicability and interpretation of electrocardiographic stress testing in patients with peripheral vascular disease. Am J Surg (1981) 0.89
Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost (2012) 0.88
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 0.88
Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials (2001) 0.88
Development of quality of care indicators for patients undergoing total hip or total knee replacement. BMJ Qual Saf (2011) 0.88
Contrast media extravasation during dynamic CT: detection with an extravasation detection accessory. Radiology (1998) 0.88
Long-term survival and quality of life following ruptured abdominal aortic aneurysm. Arch Surg (1988) 0.87
Traumatic pseudoaneurysm following blunt trauma. J Trauma (1986) 0.87